טוען...
Molecular adjuvant IL-33 enhances the potency of a DNA vaccine in a lethal challenge model
Identifying new molecular adjuvants that elicit effective vaccine-induced CD8(+) T cell immunity may be critical for the elimination of many challenging diseases including Tuberculosis, HIV and cancer. Here, we report that co-administration of molecular adjuvant IL-33 during vaccination enhanced the...
שמור ב:
| הוצא לאור ב: | Vaccine |
|---|---|
| Main Authors: | , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2015
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4546882/ https://ncbi.nlm.nih.gov/pubmed/25887087 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.vaccine.2015.03.086 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|